Anna E. Mullins, PhD, assistant professor at the Icahn School of Medicine at Mount Sinai, discusses the necessity of awareness of how health issues can present in World Trade Center (WTC) responders.
Raising awareness and implementing systematic tools to measure patient-focused outcomes can help those who responded to the 9/11 attacks, says Anna E. Mullins, PhD, assistant professor at the Icahn School of Medicine at Mount Sinai.
Mullins was the lead author of “Sleep Disorders and Chronic Rhinosinusitis in World Trade Center (WTC) Responders and a Sleep Clinic Population,” an abstract presented at the 2023 American Thoracic Society International Conference.
Transcript
What should providers and health care systems be doing to raise awareness on how sleep conditions have manifested in WTC responders?
WTC responders, with respect to sleep disorders, such as for instance, sleep apnea, they present a little differently in that they tend to have lower [body mass index], they present with more insomnia symptoms or more of an insomnia phenotype, and then they have other comorbidities that affect their sleep such as gastrointestinal reflux disorder and chronic rhinosinusitis.
Based on your findings, what can health professionals do to improve the diagnosis, treatment, and management of chronic rhinosinusitis and sleep quality in WTC responders?
There needs to be raised awareness of the differing presentation of sleep disorders and the comorbidities and to foster increasing integrative care amongst many disciplines. What my colleagues have said would be useful is more systematic tools to capture patient-focused outcomes so that the things that are meaningful to the responders can be focused on and integrated into their care.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More